12.07.2015 Views

What Works for Women and Girls

What Works for Women and Girls

What Works for Women and Girls

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

experience observed in clinical trials, focusing on sexual pleasure may increase future use.Microbicides <strong>for</strong> anal use are also under development.The first generation of microbicides is expected to be less than 100 percent effective <strong>and</strong>will ideally need to be used with a condom. However, even if used alone, a partially effectivemicrobicide could have a significant impact on HIV incidence (assuming risk taking doesnot increase with the use of this method). However, in 2009, leaders in the field of HIV/AIDS noted, “….we are still many years away from either a vaccine or a microbicide to protectagainst HIV transmission” (Piot et al., 2009: 1). <strong>Women</strong> need access to both contraceptive <strong>and</strong>non-contraceptive microbicides, because some women will want to prevent HIV, STIs, <strong>and</strong>pregnancy, while other women will want to conceive without the risk of disease transmission.Pre-Exposure ARTPre-exposure prophylaxis with antiretroviral drugs is currently being studied as a preventiontechnique. Delivery of pre-exposure prophylaxis with ART can be by oral ART pills, topical(vaginal or anal) <strong>for</strong>mulations such as gels, films, suppositories, rings or injectable/implantableantiretrovirals. Pre-exposure prophylaxis would be delivered orally <strong>and</strong> microbicideswould be delivery topically. “To date, …topical products …have not proven effective” (Mastroet al., 2008: 5). Seven human r<strong>and</strong>omized, placebo controlled clinical trials of the safety <strong>and</strong>efficacy of oral ART pre-exposure are either ongoing or planning to start in 2009 (Mastro etal., 2008). One study of daily use of pre-exposure ART in HIV-negative women did not find anassociation with clinical or laboratory adverse events (Peterson et al., 2007). The implications<strong>for</strong> women of ART <strong>for</strong> prevention, including through “test <strong>and</strong> treat,” approaches, needs tobe considered carefully. For example, an increased push <strong>for</strong> HIV testing could have negativeimplications <strong>for</strong> women. [See Chapter 6. HIV Testing <strong>and</strong> Counseling <strong>for</strong> <strong>Women</strong> <strong>and</strong> Chapter 9.Safe Motherhood <strong>and</strong> Prevention of Vertical Transmission]Prevention <strong>for</strong> All <strong>Women</strong> <strong>and</strong> <strong>Girls</strong>The prevention strategies in this chapter are applicable <strong>for</strong> all women; however certain groupsof women <strong>and</strong> girls have particular prevention needs. There<strong>for</strong>e, while this chapter presentswhat works <strong>for</strong> generally <strong>for</strong> all women, the two following chapters (Chapter 4. Prevention <strong>for</strong>Key Affected Populations <strong>and</strong> Chapter 5. Prevention <strong>for</strong> Young People) provide additional considerations<strong>and</strong> strategies <strong>for</strong> groups such as sex workers, female drug users, women <strong>and</strong> girls incomplex emergencies, young people, etc. The three chapters should be viewed together as awhole to identify what works in prevention <strong>for</strong> women.WHAT WORKS FOR WOMEN AND GIRLS49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!